296 related articles for article (PubMed ID: 27315562)
1. Renal Dialysis and its Financing.
Borelli M; Paul DP; Skiba M
Hosp Top; 2016; 94(2):33-8. PubMed ID: 27315562
[TBL] [Abstract][Full Text] [Related]
2. Medicare program; end-stage renal disease prospective payment system. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2010 Aug; 75(155):49029-214. PubMed ID: 20712086
[TBL] [Abstract][Full Text] [Related]
3. Bundled payment for ESRD--including ESAs in Medicare's dialysis package.
Iglehart JK
N Engl J Med; 2011 Feb; 364(7):593-5. PubMed ID: 21323538
[No Abstract] [Full Text] [Related]
4. Futuristic plans for ESRD--a new bundled payment system.
Michael M
Nephrol News Issues; 2005 Sep; 19(10):52, 54. PubMed ID: 16187649
[No Abstract] [Full Text] [Related]
5. Managing oral phosphate binder medication expenditures within the Medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. dialysis organizations.
Park H; Rascati KL; Keith MS
J Manag Care Spec Pharm; 2015 Jun; 21(6):507-14. PubMed ID: 26011552
[TBL] [Abstract][Full Text] [Related]
6. What can we learn from the U.S. expanded end-stage renal disease bundle?
Chambers JD; Weiner DE; Bliss SK; Neumann PJ
Health Policy; 2013 May; 110(2-3):164-71. PubMed ID: 23419419
[TBL] [Abstract][Full Text] [Related]
7. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
[TBL] [Abstract][Full Text] [Related]
8. Payment Reform and Health Disparities: Changes in Dialysis Modality under the New Medicare Dialysis Payment System.
Turenne M; Baker R; Pearson J; Cogan C; Mukhopadhyay P; Cope E
Health Serv Res; 2018 Jun; 53(3):1430-1457. PubMed ID: 28560726
[TBL] [Abstract][Full Text] [Related]
9. Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2017 Nov; 82(210):50738-97. PubMed ID: 29091373
[TBL] [Abstract][Full Text] [Related]
10. The organization and financing of kidney dialysis and transplant care in the United States of America.
Hirth RA
Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
[TBL] [Abstract][Full Text] [Related]
11. Projected impact of the proposed "bundled" ESRD payment system on a small dialysis organization.
Bhat P; Sokolowski W; Bhat JG
Nephrol News Issues; 2009 Jun; 23(7):46, 48-52. PubMed ID: 19585810
[TBL] [Abstract][Full Text] [Related]
12. Impact of reimbursement regulations on patient management.
Hull AR
Am J Kidney Dis; 1992 Jul; 20(1 Suppl 1):8-11. PubMed ID: 1626555
[TBL] [Abstract][Full Text] [Related]
13. Health Policy and Kidney Care in the United States: Core Curriculum 2020.
Mendu ML; Weiner DE
Am J Kidney Dis; 2020 Nov; 76(5):720-730. PubMed ID: 32771281
[TBL] [Abstract][Full Text] [Related]
14. How dialysis is paid for: what the dialysis medical director should know, and why.
Deoreo PB
Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell (RBC) transfusion rates among US chronic dialysis patients during changes to Medicare end-stage renal disease (ESRD) reimbursement systems and erythropoiesis stimulating agent (ESA) labels.
Cappell KA; Shreay S; Cao Z; Varker HV; Paoli CJ; Gitlin M
BMC Nephrol; 2014 Jul; 15():116. PubMed ID: 25015348
[TBL] [Abstract][Full Text] [Related]
16. Medicare program; end-stage renal disease quality incentive program. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2011 Jan; 76(3):627-46. PubMed ID: 21261127
[TBL] [Abstract][Full Text] [Related]
17. Palliative dialysis in end-stage renal disease.
Trivedi DD
Am J Hosp Palliat Care; 2011 Dec; 28(8):539-42. PubMed ID: 21398269
[TBL] [Abstract][Full Text] [Related]
18. Practice patterns, case mix, Medicare payment policy, and dialysis facility costs.
Hirth RA; Held PJ; Orzol SM; Dor A
Health Serv Res; 1999 Feb; 33(6):1567-92. PubMed ID: 10029498
[TBL] [Abstract][Full Text] [Related]
19. Paying for Frequent Dialysis.
Wilk AS; Hirth RA; Messana JM
Am J Kidney Dis; 2019 Aug; 74(2):248-255. PubMed ID: 30922595
[TBL] [Abstract][Full Text] [Related]
20. The 2011 ESRD prospective payment system: an uncontrolled experiment.
Winkelmayer WC; Chertow GM
Am J Kidney Dis; 2011 Apr; 57(4):542-6. PubMed ID: 21333428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
